1. Home
  2. BHR vs CGEN Comparison

BHR vs CGEN Comparison

Compare BHR & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BHR

Braemar Hotels & Resorts Inc.

N/A

Current Price

$2.29

Market Cap

159.3M

Sector

Real Estate

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

N/A

Current Price

$2.37

Market Cap

191.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHR
CGEN
Founded
2013
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
191.1M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
BHR
CGEN
Price
$2.29
$2.37
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
662.9K
240.4K
Earning Date
05-06-2026
05-18-2026
Dividend Yield
8.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.88
$1.30
52 Week High
$3.19
$3.24

Technical Indicators

Market Signals
Indicator
BHR
CGEN
Relative Strength Index (RSI) 61.20 53.58
Support Level $2.19 $2.22
Resistance Level $2.61 $2.54
Average True Range (ATR) 0.09 0.10
MACD 0.04 0.00
Stochastic Oscillator 97.14 47.06

Price Performance

Historical Comparison
BHR
CGEN

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: